In mice with diet-induced diabetes—the equivalent of type 2 diabetes in humans—a single injection
of the protein FGF1 is enough to restore blood sugar levels to a healthy range for more than two days. The discovery by Salk scientists, published in the journal Nature, could lead to a new generation of safer, more effective diabetes drugs.
of the protein FGF1 is enough to restore blood sugar levels to a healthy range for more than two days. The discovery by Salk scientists, published in the journal Nature, could lead to a new generation of safer, more effective diabetes drugs.
The team found that sustained treatment with the protein doesn't
merely keep blood sugar under control, but also reverses insulin
insensitivity, the underlying physiological cause of diabetes. Equally
exciting, the newly developed treatment doesn't result in side effects
common to most current diabetes treatments.
merely keep blood sugar under control, but also reverses insulin
insensitivity, the underlying physiological cause of diabetes. Equally
exciting, the newly developed treatment doesn't result in side effects
common to most current diabetes treatments.
No comments:
Post a Comment